Biotech Stock Review Adds Hancock Jaffe (HJLI) $1.05 to Watch List.
Adding to Watch List on Heels of 90 Day Results, From First Small 'In-Man' Trial to Treat Chronic Venous Insufficiency affecting the...
Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce...
Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.
Former Eastman Kodak Scientist and Engineers Develop Liquid Germ Killer Hy-IQ® to Revolutionize the way Deadly Bacteria and Virus are Eradicated
Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!
Adding Fortress to Biotech Stock Review Watch List @ $1.73.
Misunderstood by Wall Street which tends to 'over-analyze'...
SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations
Washington D.C., Aug. 20, 2019 —
The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered...
Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.
Companies With 'CoronaVirus' in Their Press Release Today:
Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”
LIVE QUOTE
How lucky, or how clever!
Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys (ATHX) $1.85
It's a bit of a stretch...
Okay, it's a bit of a stretch,...
AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
